New Guidances Expand FDA Campaign On Drug Prices

The U.S. Food and Drug Administration on Monday made its latest moves to boost lower-cost generic drugs by unveiling four new guidances, two of which directly targeted expensive medicines that are...

Already a subscriber? Click here to view full article